1. Schwarz S, Norenberg J, Berridge M, et al. The future of USP monographs for PET drugs. Journal of Nuclear Medicine. 2013;54(3):472-475
2. Food and Drug Administration Modernization Act of 1997. Washington, DC: Congress US; 1997
3. USP. Positron emission tomography drugs for compounding, investigational, and research uses, USP<823>. In: The United States Pharmacopeia, 40th Rev., and the National Formulary, 35th Ed. 40 Ed. Rockville, MD: United States Pharmacopeial Convention, Inc.; 2017. pp. 758-768
4. U.S. Pharmacopeial Convention. USP 22–NF 17, Fludeoxyglucose F 18 Injection. Rockville, MD: U.S. Pharmacopeial Convention; 1990:579-580
5. Decristoforo C, Patt M. Are we “preparing” radiopharmaceuticals? EJNMMI Radiopharmacy and Chemistry. 2017;2(1):12